GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 82 filers reported holding GLYCOMIMETICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | +20.0% | 500 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $5,000 | -28.6% | 500 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $7,000 | -12.5% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | 0.0% | 500 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $8,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,426,282 | $17,348,000 | 3.27% |
| NEA Management Company, LLC | 8,584,128 | $61,377,000 | 2.76% |
| SPHERA FUNDS MANAGEMENT LTD. | 718,080 | $5,134,000 | 0.84% |
| WALL STREET ASSOCIATES | 150,000 | $1,072,000 | 0.36% |
| Cormorant Asset Management, LP | 287,031 | $2,052,000 | 0.23% |
| Candriam S.C.A. | 160,000 | $1,144,000 | 0.03% |
| PRENTISS SMITH & CO INC | 7,000 | $50,000 | 0.03% |
| Baker Brothers Advisors | 381,235 | $2,726,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,764 | $785,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,762,807 | $19,754,000 | 0.01% |